Navigation Links
Mosio Announces mPIN™ Technology for Clinical Research
Date:9/28/2017

Today, Mosio, a mobile solutions provider for clinical research, announces its new mPIN™ technology. Mosio’s mPIN™ adds a new layer of security and verification to text messaging communications with participants in clinical research studies.

Researchers are looking to improve the ways they communicate with, engage, and collect data from study participants. Emails and phone calls aren’t as effective as they used to be in engaging study subjects before and during trials, so many researchers are turning to text messaging as an effective tool. Text messaging, the most utilized feature on mobile phones, is an efficient way to communicate, but it is still considered new in clinical trials. Its growing use in the industry has researchers looking for new ways SMS can be used to make studies more efficient, effective, and engaging.

Mosio’s mPIN™ technology offers new, improved verification and security measures on the text messaging channel to better meet the needs of clients involved in sending and receiving sensitive information in clinical trials.

How it Works
1. At the beginning of the project, study staff add subjects to the system and ask them for an easy-to-remember PIN (personal identification number), which becomes the participant’s mPIN.
2. Before a message with sensitive information is sent or before a survey starts, a single text message asks for their PIN. After they enter it correctly they will get the message or start a survey.
3. After the participants complete the survey or message transmission, a thank you message encourages them to delete all of the messages (incoming and outgoing) from their text history.

The creation of mPIN™ came from research clients seeing the benefit of using text messaging in clinical studies over mobile apps, but needing a better way to verify the study participant was the one reading and responding to a message or SMS survey.

The result is mPIN™, another mobile messaging innovation in research setting Mosio apart from general text messaging providers. While mPIN™ is groundbreaking, it is simple to use and works on the SMS channel available on 99% of mobile phones. mPIN™ improves privacy and verification in study participant communications and data collection, backed by a HIPAA-compliant hosted platform and a unique, alphanumeric, user-based PIN for each study participant. Further, because text messages don't use "read receipts" after sending, mPIN™ provides visibility to research teams that a participant received the message. Friendly reminders or "nudges" can be sent when a participant hasn't responded to a message or finished a survey, tackling another adherence issue in clinical studies.

Specializing in clinical research gives the company more freedom to create inventive solutions in the industry and concentrate on study team challenges. "Mosio's focus on creating mobile messaging solutions specifically for the clinical research industry enables us to innovate based on the needs and workflow processes of study staff while also improving the trial experience for patients and participants," said Noel Chandler, CEO of Mosio.

“mPIN was created to fill a need in clinical trial communications and patient engagement, based on feedback from research teams. It's a perfect example of how clients help our team develop new technologies, using the most popular mobile channel in the world: text messaging," added Chandler.

With mPIN, Mosio furthers its mission to create innovative clinical research solutions accessible to all study patients and participants.

About Mosio
Mosio is dedicated to increasing the success of clinical trials, worldwide, through mobile messaging technologies. Its mobile software platform offers clinical trial sponsors, CROs, and NIH-funded studies an efficient, cost-effective way to communicate efficiently with study subjects. Researchers use Mosio to extend their outreach and stay connected to participants through interactive, two-way text message alerts, reminders, and surveys in over 48 countries. Researchers benefit by using Mosio's software to recruit, retain, engage, and collect data from study participants via their own mobile phones.

For more information on Mosio’s mPIN™ technology, visit http://www.mosio.com/mpin

To learn more about Mosio’s mobile messaging solutions for clinical research, visit http://www.mosio.com or call/text 415-799-4144.

Read the full story at http://www.prweb.com/releases/2017/09/prweb14710820.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Aesthetic Business Institute Announces Initial Advisory Board Leaders; Prominent Clinicians and Business Leaders Selected to Serve on ABI’s Advisory Boards.
2. United Way of Greater Los Angeles Announces 11th Annual HomeWalk To End Homelessness in L.A. County
3. ISPE Announces 2017–2018 Board of Directors Election Results
4. The American Society of Nuclear Cardiology (ASNC) Announces the Publication of Its New Imaging Guidelines for Nuclear Cardiology Procedures
5. New Dermatology, Cosmetic and Aesthetic Management Group Announces its Inception
6. First Choice Emergency Room Announces Dr. Leigh Galatzan as Medical Director of Austin, Texas Facility
7. Orthopedic and Back Pain Centers of America Announces Kathy Hebert Has Joined as Healthcare Partnerships Consultant
8. The John R. Elliott HERO Campaign for Designated Drivers Announces HEROtini Happening Event Winners
9. FDAnews Announces — New Management Report — Principles of Equipment Qualification: A Guide for Drug and Device Manufacturers
10. FDAnews Announces: Data Integrity: The Key to FDA and GMP Compliance, Dec. 5-6, 2017, Arlington, VA
11. Pittcon Announces New Committee Leadership for Pittcon 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... Bethesda, MD (PRWEB) , ... October 12, 2017 , ... ... Award of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s ... 4 – 8. , In honor of Morris F. Collen, a pioneer in the ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... ... 12, 2017 , ... HMP , a leader in healthcare events and ... Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie ... annual award competition recognizes editorial and design excellence across a range of sectors. This ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the ... – Miles by Moonlight to raise money for the American Heart Association Heart Walk. ... , Teams will work together to keep their treadmills moving for 5 hours. Treadmills ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... , Oct. 12, 2017   Divoti USA ... Jewelry up to the standard of the latest FDA requirements, which ... 2017). Anyone in need of Medical ID jewelry such ... Alert Jewelry are engraved in terms of the new ... Divoti offers ...
(Date:10/11/2017)... 11, 2017  Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), ... in Las Piedras, Puerto Rico , ... Following a ... sustained minor structural damage, temporary loss of power and ... been completed, manufacturing operations have resumed, and the company ...
(Date:10/4/2017)... 2017  South Korean-based healthcare product Development Company I.M. ... on Kickstarter. The device will educate the user about ... better efficiency compared to the dated and pricey CPR ... efficacy of the compression for a more informed CPR ... to raise $5,000. ...
Breaking Medicine Technology: